Found 30 matching trials
Neoadjuvant Letrozole in Postmenopausal Women With Hormone Receptor-Positive, HER2-Negative, Node Positive, Early-Stage Breast Cancer. PHASE2 The goal of this clinical trial is to learn whether letrozole, a hormone th...
Show More Location
Cancer Care Hospital and Research Centre Foundation
Learn More & Join Trial
Comparison Study of Letrozole Alone or Letrozole With Zoledronic Acid in Early Breast Cancer, Neoadjuvant Therapy PHASE2 This study is to measure the extent of tumor shrinkage when Letrozole and Z...
Show More Location
Novartis Investigative Site
Learn More & Join Trial
A Study to Learn About the Study Medicine PF-07220060 Together With Letrozole Compared to Letrozole Alone in Women Post Menopause PHASE2 The purpose of this study is to learn about the effects of the study medici...
Show More Location
Advocate Good Shepherd Hospital
Learn More & Join Trial
Combination of Letrozole, Everolimus and TRC105 in Postmenopausal Women With Hormone-Receptor Positive and Her2 Negative Breast Cancer PHASE1 This study will test how well a new combination of three drugs (Letrozole, ...
Show More Location
University of Alabama at Birmingham
Learn More & Join Trial
Neoadjuvant Endocrine Therapy, Palbociclib, Avelumab in Estrogen Receptor Positive Breast Cancer PHASE2 Eligible patients with estrogen receptor positive breast cancer will underg...
Show More Status
Active Not Recruiting
Location
University of Alabama at Birmingham
Learn More & Join Trial
Optimal Duration of Pre-operative Treatment With Letrozole and to Correlate Clinical Efficacy With Appropriate Surrogate Markers PHASE2 This study will assess optimal duration of pre-operative treatment with let...
Show More Location
Multiple Locations
Learn More & Join Trial
Neoadjuvant Combined Endocrine and HER2 Target Therapy in Postmenopausal Women With ER and Her2 Positive Breast Cancer PHASE2 Cross-talk between epidermal growth factors and the ER occurs at multiple l...
Show More Location
Asan Nedical Center
Learn More & Join Trial
PErsonalized TREatment of High-risk MAmmary Cancer - the PETREMAC Trial PHASE2 Breast cancer is an optimal "model disease" for studying personalized medic...
Show More Status
Active Not Recruiting
Location
Akershus University Hospital
Learn More & Join Trial
Neoadjuvant Letrozole in Treating Postmenopausal Women With Estrogen-Receptor Positive and/or Progesterone-Receptor Positive Stage II, Stage IIIA, or Stage IIIB Breast Cancer PHASE2 RATIONALE: Estrogen can stimulate the growth of breast cancer cells. Hormon...
Show More Location
Washington University School of Medicine
Learn More & Join Trial
Study of Letrozole With or Without BYL719 or Buparlisib, for the Neoadjuvant Treatment of Postmenopausal Women PHASE2 The purpose of the study was to determine whether treatment with a PI3K inh...
Show More Location
University of Alabama at Birmingham/ Kirklin Clinic Univ AL - PI
Learn More & Join Trial